Polycystic Ovary Syndrome and Inflammation

Peter Chedraui, Faustino R. Pérez-López

Producción científica: Capítulo del libro/informe/acta de congresoCapítulorevisión exhaustiva

Resumen

The polycystic ovary syndrome (PCOS) is the most prevalent female endocrine disorder in which hyperandrogenism is the main clinical feature. These steroids contribute to excessive weight gain, insulin resistance, hirsutism, acne, and androgenic alopecia. Visceral fat hypertrophy and androgen excess correlates with the degree of insulin resistance, the worse PCOS phenotype, and cardiovascular risk factors. Abnormal secretion of many adipocyte-derived products will produce a state of chronic low-intensity inflammation that progressively affects every organ and system. Appropriate nutrition, physical activity, and exercise may improve body composition, and metabolic and endocrine functioning. Different supplements (minerals, vitamins, and probiotics) may also contribute to neutralize the evolution of the syndrome.

Idioma originalInglés
Título de la publicación alojadaInternational Society of Gynecological Endocrinology Series
EditorialSpringer Nature
Páginas179-189
Número de páginas11
DOI
EstadoPublicada - 2021
Publicado de forma externa

Serie de la publicación

NombreInternational Society of Gynecological Endocrinology Series
ISSN (versión impresa)2197-8735
ISSN (versión digital)2197-8743

Huella

Profundice en los temas de investigación de 'Polycystic Ovary Syndrome and Inflammation'. En conjunto forman una huella única.

Citar esto